A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Clinical trial NCT02570308 · COMPLETED
Trial details
- NCT number
- NCT02570308
- Sponsor
- Immunocore Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2020-03-20
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.